What question did this study set out to answer?

This research aimed to evaluate the inhibitory function of the CD19 antibody HD37 on B cell activation and proliferation.

CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates CD19 mAb HD37’s effects on B cell activation, indicating potential for immune modulation.

This research aimed to evaluate the inhibitory function of the CD19 antibody HD37 on B cell activation and proliferation.
Evaluated the effects of low doses of CD19 mAb HD37 (0.5 microgram/ml) on B cell responses.
Analyzed dose-response relationships and utilized cross-linking antibodies to assess CD19 inhibition.
Measured intracellular calcium flux and the progression of B cells from G0 to G1 phase of the cell cycle.
HD37 mAb caused a significant reduction in B cell proliferation in response to anti-Ig.
Inhibition of [Ca2+]i increase due to anti-Ig was observed, suggesting a relationship between calcium flux and proliferation.
Cross-linking of CD19 antigens was essential for maximal inhibitory effects on B cell activation.

Pezzutto et al. (1987) studied this question.

View Full Paper

Ask AI

Bookmark